{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:48:32Z","timestamp":1790005712341,"version":"4.0.1"},"reference-count":33,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,11,1]]},"abstract":"<jats:sec><jats:title>Objectives.<\/jats:title><jats:p>Febrile seizures recur frequently. Factors increasing the risk of febrile seizure recurrence include young age at onset, family history of febrile seizures, previous recurrent febrile seizures, time lapse since previous seizure &amp;lt;6 months, relative low temperature at the initial seizure, multiple type initial seizure, and frequent febrile illnesses. Prevention of seizure recurrences serves two useful purposes: meeting parental fear of recurrent febrile seizures in general and reducing the (small) risk of a long-lasting and eventually injurious recurrent seizure. In daily practice, children with febrile seizures often are treated with antipyretics during fever to prevent febrile seizure recurrences. Thus far, no randomized placebo-controlled trial has been performed to assess the efficacy of intermittent antipyretic treatment in the prevention of seizure recurrence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We performed a randomized, double-blind, placebo-controlled trial. Children 1 to 4 years of age who had had at least one risk factor for febrile seizure recurrence were enrolled. They were randomly assigned to either ibuprofen syrup, 20 mg\/mL, 0.25 mL (= 5 mg) per kilogram of body weight per dose, or matching placebo, to be administered every 6 hours during fever (temperature, \u226538.5\u00b0C). Parents were instructed to take the child's rectal temperature immediately when the child seemed ill or feverish and to promptly administer the study medication when the temperature was \u226538.5\u00b0C. Doses were to be administered every 6 hours until the child was afebrile for 24 hours. The parents were instructed not to administer any other antipyretic drug to the child. For measuring rectal temperature, a Philips HP5316 digital thermometer (Philips, Eindhoven, The Netherlands) was distributed. During subsequent treatment of the fever episode, parents had to call the investigator at least once each day to notify the investigator in case of febrile seizure recurrence. The investigator could be contacted by parents 24 hours per day.<\/jats:p><jats:p>The primary outcome was the first recurrence of a febrile seizure. Kaplan\u2013Meier curves and Cox regression were used for the statistical analysis. The treatment effect on the course of the temperature was assessed using analysis of covariance, with temperature at fever onset as covariate. Two analyses were performed. In an intention-to-treat analysis, all first recurrences were considered regardless of study medication compliance. A per-protocol analysis was limited to those recurrences that occurred in the context of study medication compliance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Between October 1, 1994, and April 1, 1996, 230 children were randomly assigned to ibuprofen syrup (111 children) or placebo (119 children). Median follow-up time was 1.04 years (25th\u201375th percentiles; 0.7\u20131.8 years) in the ibuprofen group and 0.98 years (0.7\u20131.6 years) in the placebo group. Of all children, 67 had a first febrile seizure recurrence, with 31 in the ibuprofen group and 36 in the placebo group. The 2-year recurrence probabilities were 32% and 39%, respectively. The recurrence risk in the ibuprofen group was 0.9 (95% confidence interval: 0.6\u20131.5) times the recurrence risk in the placebo group (intention to treat). Adjustment for baseline characteristics did not affect the risk-reduction estimate. Of the 67 recurrences, 30 occurred in the context of study medication compliance (13 ibuprofen, 17 placebo). The per-protocol analysis, which was limited to these events, showed similar results.<\/jats:p><jats:p>A significant reduction in temperature (0.7\u00b0C) after fever onset in the ibuprofen group compared with the placebo group was demonstrated if all 555 fever episodes were considered. In the fever episodes with a seizure recurrence, a similar temperature increase was shown in both groups, with no significant difference between the intention-to-treat and the per-protocol analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion.<\/jats:title><jats:p>The present study failed to demonstrate a preventive effect of intermittent antipyretic treatment during fever on the number of febrile seizure recurrences in children at increased risk. The possibility that antipyretics can reduce recurrence has been addressed before. None of these studies were placebo-controlled trials with a standardized antipyretic treatment schedule; hence, the results were inconclusive.<\/jats:p><jats:p>Although it had been described previously that ibuprofen reduces fever safely and adequately in children with febrile seizures, which is confirmed by the present study, we found that fever was not reduced in those fever episodes in which a recurrence occurred. Factors that may have influenced these results are discussed.<\/jats:p><jats:p>Preventive treatment alternatives include primarily intermittent treatment with diazepam. Only children with a high recurrence risk may benefit from it. In a meta-analysis, its efficacy could not be demonstrated. The most important issue in treating children with febrile seizures is reducing parental anxiety by providing information about the excellent prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>We found no evidence that ibuprofen administration during fever prevents febrile seizure recurrence.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.102.5.e51","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:44:32Z","timestamp":1092440672000},"page":"e51-e51","source":"Crossref","is-referenced-by-count":86,"title":["Randomized, Controlled Trial of Ibuprofen Syrup Administered During Febrile Illnesses to Prevent Febrile Seizure Recurrences"],"prefix":"10.1542","volume":"102","author":[{"given":"Margriet","family":"van Stuijvenberg","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Sophia Children's Hospital, Rotterdam, The Netherlands;"},{"name":"Department of Public Health, Erasmus University, Rotterdam, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerarda","family":"Derksen-Lubsen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Juliana Children's Hospital, The Hague, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewout W.","family":"Steyerberg","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus University, Rotterdam, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Dik F","family":"Habbema","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus University, Rotterdam, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrie\u0308tte A.","family":"Moll","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Sophia Children's Hospital, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[1998,11,1]]},"reference":[{"key":"2021121000274909100_B1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-3016.1991.tb00699.x","article-title":"Prevalence of febrile seizures in Dutch schoolchildren.","volume":"5","author":"Offringa","year":"1991","journal-title":"Paediatr Perinat Epidemiol."},{"key":"2021121000274909100_B2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/bmj.290.6478.1307","article-title":"Febrile convulsions in a national cohort followed up from birth. I. Prevalence and recurrence in the first year of life.","volume":"290","author":"Verity","year":"1985","journal-title":"Br Med J."},{"key":"2021121000274909100_B3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3476(05)82816-1","article-title":"Predictors of recurrent febrile seizures: a metaanalytic review.","volume":"116","author":"Berg","year":"1990","journal-title":"J Pediatr."},{"key":"2021121000274909100_B4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1056\/NEJM199210153271603","article-title":"A prospective study of recurrent febrile seizures","volume":"327","author":"Berg","year":"1992","journal-title":"N Engl J Med."},{"key":"2021121000274909100_B5"},{"key":"2021121000274909100_B6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0022-3476(05)83136-1","article-title":"Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data of five studies.","volume":"124","author":"Offringa","year":"1994","journal-title":"J Pediatr."},{"key":"2021121000274909100_B7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1600-0404.1988.tb03678.x","article-title":"Frequent febrile episodes and recurrent febrile convulsions.","volume":"78","author":"Knudsen","year":"1988","journal-title":"Acta Neurol Scand."},{"key":"2021121000274909100_B8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.1994.tb02707.x","article-title":"Risk factors for recurrences of febrile convulsions.","volume":"90","author":"Rantala","year":"1994","journal-title":"Acta Neurol Scand."},{"key":"2021121000274909100_B9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/adc.78.1.78","article-title":"Do seizures damage the brain? The epidemiological evidence.","volume":"78","author":"Verity","year":"1998","journal-title":"Arch Dis Child."},{"key":"2021121000274909100_B10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1528-1157.1997.tb01245.x","article-title":"Recurrent seizures in the developing brain are not harmful.","volume":"38","author":"Camfield","year":"1997","journal-title":"Epilepsia."},{"key":"2021121000274909100_B11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00004691-199703000-00003","article-title":"Do seizures beget seizures? An assessment of the clinical evidence in humans.","volume":"14","author":"Berg","year":"1997","journal-title":"J Clin Neurophysiol."},{"key":"2021121000274909100_B12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1651-2227.1991.tb11883.x","article-title":"Parental reactions to a child's first febrile convulsion.","volume":"80","author":"Balslev","year":"1991","journal-title":"Acta Paediatr Scand."},{"key":"2021121000274909100_B13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1469-8749.1981.tb02019.x","article-title":"Many parents think their child is dying when having a first febrile convulsion.","volume":"23","author":"Baumer","year":"1981","journal-title":"Dev Med Child Neurol."},{"key":"2021121000274909100_B14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0022-3476(97)70045-3","article-title":"A meta-analytic review of the preventive treatment of recurrences of febrile seizures.","volume":"131","author":"Rantala","year":"1997","journal-title":"J Pediatr."},{"key":"2021121000274909100_B15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(80)80122-3","article-title":"The first febrile seizure\u2014antipyretic instruction plus either phenobarbital or placebo to prevent recurrence.","volume":"97","author":"Camfield","year":"1980","journal-title":"J Pediatr."},{"key":"2021121000274909100_B16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/BF01953992","article-title":"Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage.","volume":"152","author":"Schnaidermann","year":"1993","journal-title":"Eur J Pediatr."},{"key":"2021121000274909100_B17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3476(95)70231-8","article-title":"Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures.","volume":"126","author":"Uhari","year":"1995","journal-title":"J Pediatr."},{"key":"2021121000274909100_B18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1542\/peds.66.6.1009","article-title":"Febrile seizures.","volume":"66","author":"Consensus Development Conference","year":"1980","journal-title":"Pediatrics."},{"key":"2021121000274909100_B19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimates from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"Am Stat Assoc."},{"key":"2021121000274909100_B20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc [B]."},{"key":"2021121000274909100_B21","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/sim.4780111304","article-title":"Repeated measures in clinical trials using mean summary statistics and its implications for design.","volume":"11","author":"Frison","year":"1992","journal-title":"Stat Med."},{"key":"2021121000274909100_B22"},{"key":"2021121000274909100_B23"},{"key":"2021121000274909100_B24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-3476(05)80307-5","article-title":"Single dose, placebo controlled comparative study of ibuprofen and acetaminophen antipyresis in febrile children.","volume":"119","author":"Wilson","year":"1991","journal-title":"J Pediatr."},{"key":"2021121000274909100_B25","first-page":"626","article-title":"Comparison of multidose ibuprofen and acetaminophen therapy in febrile children.","volume":"146","author":"Walson","year":"1992","journal-title":"Am J Dis Child."},{"key":"2021121000274909100_B26"},{"key":"2021121000274909100_B27"},{"key":"2021121000274909100_B28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0022-3476(85)80688-0","article-title":"Effective short term diazepam prophylaxis in febrile convulsions.","volume":"106","author":"Knudsen","year":"1985","journal-title":"J Pediatr."},{"key":"2021121000274909100_B29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-3476(05)81104-7","article-title":"Double-blind, randomized trial of diazepam versus placebo for prevention of recurrence of febrile seizures.","volume":"117","author":"Autret","year":"1990","journal-title":"J Pediatr."},{"key":"2021121000274909100_B30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0404.1990.tb01581.x","article-title":"Intermittent prophylaxis in febrile convulsions: diazepam or valproic acid?","volume":"82","author":"Daugbjerg","year":"1990","journal-title":"Acta Neurol Scand."},{"key":"2021121000274909100_B31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM199307083290202","article-title":"A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures.","volume":"329","author":"Rosman","year":"1993","journal-title":"N Engl J Med."},{"key":"2021121000274909100_B32","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1542\/peds.75.6.1110","article-title":"Parental fever phobia and its correlates.","volume":"75","author":"Kramer","year":"1985","journal-title":"Pediatrics."},{"key":"2021121000274909100_B33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM199210153271610","article-title":"The best medicine for febrile seizures.","volume":"327","author":"Freeman","year":"1992","journal-title":"N Engl J Med."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/102\/5\/e51\/840315\/e51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/102\/5\/e51\/840315\/e51.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:32:57Z","timestamp":1734507177000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/102\/5\/e51\/61983\/Randomized-Controlled-Trial-of-Ibuprofen-Syrup"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11,1]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[1998,11,1]]},"published-print":{"date-parts":[[1998,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.102.5.e51","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1998,11,1]]}}}